<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01183520</url>
  </required_header>
  <id_info>
    <org_study_id>GFHNRC017</org_study_id>
    <nct_id>NCT01183520</nct_id>
  </id_info>
  <brief_title>Effect of High Omega-3 Fish Intake on Lipid Peroxidation</brief_title>
  <official_title>Effect of High Omega-3 Fish Intake on Lipid Peroxidation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>USDA Grand Forks Human Nutrition Research Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>USDA Beltsville Human Nutrition Research Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Dakota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>USDA Grand Forks Human Nutrition Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this project is to identify an appropriate level of high omega-3 fish
      (salmon) consumption that will promote optimal omega 3 nutritional status without increasing
      the level of lipid oxidation in the body.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies have demonstrated that the intakes of fatty fish and fish oils are associated with
      decreases in cardiovascular disease and other chronic disease states. This is related to the
      long chain omega-3 fatty acid (n-3) content of fish and fish oil, specifically
      eicosapentaenoic acid and docosahexaenoic acid. Although the consumption of high n-3 fish is
      recommended in the 2005 US Dietary Guidelines for Americans, no specific consumption levels
      are made for the fatty acid eicosapentaenoic acid (EPA) and/or the fatty acid docosahexaenoic
      acid (DHA) or total fish intake.

      Consumption of high n-3 fish or dietary supplementation of fish oil will lead to increased
      levels of these fatty acids in plasma lipoproteins, cell and tissue lipid. This change in
      membrane lipid is thought to be responsible for the anti-inflammatory effects of n-3. Because
      highly unsaturated fatty acid are subject to peroxidation, the level of fish intake that is
      sufficient to modify membrane n-3 content and the exact level that enhances peroxidation is
      unknown.

      We will perform a dose-response feeling study in which varied levels of fish (salmon) will be
      provided in random order separated by 4 or more week washout periods. We will assess the
      level of cell membrane enrichment with n-3 and the effect on lipid peroxidation outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Long chain omega-3 fatty acid (n-3)</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of different levels of n-3 intake on n-3 fatty acids in plasma lipoproteins, cell and tissue lipids (cell enrichment)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>lipid peroxidation</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of different levels of n-3 intake on lipid peroxidation</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Omega-3 Fatty Acids</condition>
  <condition>Lipid Peroxidation</condition>
  <arm_group>
    <arm_group_label>90 grams of Salmon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will consume 90 grams of salmon twice a week for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>180 grams of salmon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will consume 180 grams of salmon twice a week for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>270 Grams of Salmon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will consume 270 grams of salmon twice a week for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega-3 fish oil provided by salmon</intervention_name>
    <description>Eating 3 different amounts of provided salmon twice a week for four weeks</description>
    <arm_group_label>90 grams of Salmon</arm_group_label>
    <arm_group_label>180 grams of salmon</arm_group_label>
    <arm_group_label>270 Grams of Salmon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 25-34.9

          -  Non-smoker

          -  Free of major medical conditions

          -  Willing to comply with protocol requirements

        Exclusion Criteria:

          -  Use of lipid modifying drugs or supplements

          -  Taking fish oil or flax supplements

          -  Regular fish consumer

          -  Planning to gain to lose weight

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan K Raatz, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>USDA Grand Forks Human Nutrition Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>USDA ARS Grand Forks Human Nutrition Research Center</name>
      <address>
        <city>Grand Forks</city>
        <state>North Dakota</state>
        <zip>58202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Holman RT. Control of polyunsaturated acids in tissue lipids. J Am Coll Nutr. 1986;5(2):183-211. Review.</citation>
    <PMID>2873160</PMID>
  </reference>
  <reference>
    <citation>Raatz SK, Bibus D, Thomas W, Kris-Etherton P. Total fat intake modifies plasma fatty acid composition in humans. J Nutr. 2001 Feb;131(2):231-4.</citation>
    <PMID>11160538</PMID>
  </reference>
  <reference>
    <citation>Roberts LJ 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1998 May 29;273(22):13605-12.</citation>
    <PMID>9593698</PMID>
  </reference>
  <reference>
    <citation>Song WL, Paschos G, Fries S, Reilly MP, Yu Y, Rokach J, Chang CT, Patel P, Lawson JA, Fitzgerald GA. Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation. J Biol Chem. 2009 Aug 28;284(35):23636-43. doi: 10.1074/jbc.M109.024075. Epub 2009 Jun 11.</citation>
    <PMID>19520854</PMID>
  </reference>
  <reference>
    <citation>Roberts LJ 2nd, Fessel JP. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids. 2004 Mar;128(1-2):173-86. Review.</citation>
    <PMID>15037162</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2010</study_first_submitted>
  <study_first_submitted_qc>August 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2010</study_first_posted>
  <last_update_submitted>September 24, 2013</last_update_submitted>
  <last_update_submitted_qc>September 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>USDA Grand Forks Human Nutrition Research Center</investigator_affiliation>
    <investigator_full_name>Susan Raatz</investigator_full_name>
    <investigator_title>PhD, RD, Research Nutritionist</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

